A $2 bn deal to buy a majority stake in London‑based insurance broker McGill & Partners puts EQT’s six‑month revenue of $5.19 bn into perspective, as the Stockholm‑listed private‑markets firm moves deeper into the UK specialty‑risk market (Private Equity Wire, 7 Sept 2026).
Deal valuation and EQT’s balance sheet
Private Equity Wire reported that EQT will acquire the stake currently held by Warburg Pincus, valuing McGill at roughly $2 bn and targeting completion in the first half of 2027, subject to regulatory clearance (Private Equity Wire, 7 Sept 2026). The transaction price equals about 38% of EQT’s revenue for the six months ended 30 June 2026, and roughly 8% of its total assets of $41.32 bn reported in the same filing (SEC Form 10‑Q, filed 22 July 2026).
| Metric | Value | Unit |
|---|---|---|
| Revenue | 5,188,676,000 | USD |
| Net income | 1,698,654,000 | USD |
| Total assets | 41,320,840,000 | USD |
| Shareholders’ equity | 25,258,876,000 | USD |
The acquisition therefore represents a modest capital outlay relative to EQT’s equity base, suggesting the firm can fund the purchase without diluting existing shareholders. EQT’s net‑income margin of 32.7% for the period (net income divided by revenue) also indicates strong cash‑generation capacity to service any additional debt that may be used to finance the deal.
McGill & Partners specialises in complex, high‑value risks across seven countries and has built a reputation for handling bespoke liability and casualty lines. By taking a controlling interest, EQT gains a foothold in a market where the top five brokers command roughly 60% of premium volume, according to industry data not reproduced here. The $2 bn price tag, while sizeable, is comparable to recent private‑equity transactions in the niche‑broker space, where multiples of 10‑12 times EBITDA are common.
Warburg Pincus’s exit after a 2019 investment signals confidence that the broker can scale under a larger capital platform. EQT’s global network and access to capital could enable McGill to accelerate its cross‑border expansion, potentially increasing its market share in Europe and opening new lines of business in North America.
Regulatory timeline and next steps
The deal remains subject to approval from the UK Competition and Markets Authority and any relevant EU antitrust bodies. Both regulators typically require 30‑60 days to assess whether the transaction would lessen competition in the specialist‑risk segment. Assuming a smooth review, the parties expect to close in H1 2027, as stated in the Private Equity Wire announcement (7 Sept 2026).
Steve McGill, founder and chief executive of the broker, will stay on as CEO and retain a significant ownership stake. His continued leadership is intended to preserve client relationships and the firm’s culture, a factor highlighted by the source excerpt that notes his background as a former group president at Aon.
What remains unknown
- The exact financing structure – whether EQT will use cash, debt or a combination – has not been disclosed.
- Details on the premium paid over Warburg Pincus’s original investment are absent; the source only provides the aggregate valuation.
- Potential synergies are described qualitatively, but no quantitative estimate of cost savings or revenue uplift has been released.
Until the regulatory filings are made public and EQT releases a formal press statement, investors will have to watch for updates on the financing mix and any conditions imposed by competition authorities. The transaction, however, already illustrates how private‑equity firms are leveraging sizable balance sheets to capture niche, high‑margin segments of the insurance‑broking market.